Bio-Rad Laboratories (BIO) Share-based Compensation (2009 - 2025)

Bio-Rad Laboratories (BIO) has reported Share-based Compensation for 17 consecutive years, with $15.9 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Share-based Compensation fell 3.05% year-over-year to $15.9 million in Q4 2025; TTM through Dec 2025 was $62.8 million, a 2.03% decrease from a year earlier, with the FY2025 full-year figure at $58.0 million, down 6.9% from the prior year.
• Share-based Compensation was $15.9 million for Q4 2025 at Bio-Rad Laboratories, up from $14.9 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $18.1 million in Q4 2022 and troughed at $11.4 million in Q2 2021.
• A 5-year average of $14.8 million and a median of $15.3 million in 2021 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation increased 29.55% in 2021 and retreated 10.5% in 2023, its largest moves.
• Over 5 years, Share-based Compensation stood at $15.0 million in 2021, then grew by 20.67% to $18.1 million in 2022, then retreated by 10.5% to $16.2 million in 2023, then advanced by 1.23% to $16.4 million in 2024, then declined by 3.05% to $15.9 million in 2025.
• The last three Share-based Compensation figures came in at $15.9 million (Q4 2025), $14.9 million (Q3 2025), and $16.4 million (Q4 2024), per Business Quant data.